NCT04541563View on ClinicalTrials.gov

Fisher Wallace Neurostimulation & Depression Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

August 24, 2020

Primary Completion Date

March 30, 2021

Study Completion Date

November 30, 2021

Conditions
Major Depressive Disorder
Interventions
DEVICE

Fisher Wallace Cranial Electrotherapy Stimulator Device

Fisher Wallace Stimulator®, a patented cranial electrotherapy stimulation device that was cleared by the FDA in 1991 for the treatment of depression, anxiety and insomnia.

Trial Locations (1)

10003

ProofPilot (Remote Virtual Trial), New York

All Listed Sponsors
collaborator

Fisher Wallace

UNKNOWN

lead

ProofPilot

INDUSTRY